Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre‐treatment against 3,4‐methylenedioxymethamphetamine toxicity in rat brain
Authors:
- 22 January 2007
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 101 (5) , 1272-1283
Abstract
3,4‐Methylenedioxymethamphetamine (MDMA, ‘ecstasy’) produces acute hyperthermia which increases the severity of the selective serotoninergic neurotoxicity produced by the drug in rats. Heat shock protein 70 (Hsp70) is a major inducible cellular protein expressed in stress conditions and which is thought to exert protective functions. MDMA (12.5 mg/kg, i.p.), given to rats housed at 22°C, produced an immediate hyperthermia and increased Hsp70 in frontal cortex between 3 h and 7 days after administration. MDMA, given to rats housed at low ambient temperature (4°C) produced transient hypothermia followed by mild hyperthermia but no increase in Hsp70 expression, while rats treated at elevated room temperature (30°C) showed enhanced hyperthermia and similar expression of Hsp70 to that seen in rats housed at 22°C. Fluoxetine‐induced inhibition of 5‐HT release and hydroxyl radical formation did not modify MDMA‐induced Hsp70 expression 3 h later. Four‐ or 8‐day heat shock (elevation of basal rectal temperature by 1.5°C for 1 h) or geldanamycin pre‐treatment induced Hsp70 expression and protected against MDMA‐induced serotoninergic neurotoxicity without affecting drug‐induced hyperthermia. Thus, MDMA‐induced Hsp70 expression depends on the drug‐induced hyperthermic response and not on 5‐HT release or hydroxyl radical formation and pre‐induction of Hsp70 protects against the long‐term serotoninergic damage produced by MDMA.Keywords
This publication has 58 references indexed in Scilit:
- MDMA‐induced neurotoxicity: long‐term effects on 5‐HT biosynthesis and the influence of ambient temperatureBritish Journal of Pharmacology, 2006
- (±)-3,4-Methylenedioxymethamphetamine Administration to Rats Does Not Decrease Levels of the Serotonin Transporter Protein or Alter Its Distribution between Endosomes and the Plasma MembraneThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Hsp70 Overexpression Sequesters AIF and Reduces Neonatal Hypoxic/Ischemic Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2005
- 3,4‐Methylenedioxymethamphetamine increases interleukin‐1β levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5‐HT depletionJournal of Neurochemistry, 2004
- Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsyAnnals of Neurology, 1998
- Ischemic Preconditioning and Brain Tolerance: Temporal Histological and Functional Outcomes, Protein Synthesis Requirement, and Interleukin-1 Receptor Antagonist and Early Gene ExpressionStroke, 1998
- Estimating Hydroxyl Radical Content in Rat Brain Using Systemic and Intraventricular Salicylate: Impact of MethamphetamineJournal of Neurochemistry, 1995
- Enhanced hydroxyl radical generation by 2′‐methyl analog of MPTP: Suppression by clorgyline and deprenylSynapse, 1992
- Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the ratPharmacology Biochemistry and Behavior, 1991
- Hydroxylation of salicylate as an assay for hydroxyl radicals: A cautionary noteFree Radical Biology and Medicine, 1991